{
  "Variants Include": [
    {
      "Gene": "UBR5",
      "variants": [
        {
          "HGVS": "NM_001126112.3:c.935G>A",
          "cDNA Change": {
            "transcript": "NM_001126112.3",
            "ref": "G",
            "alt": "A",
            "position": "935"
          },
          "Protein Change": {
            "ref": "E",
            "alt": "K",
            "position": "312"
          },
          "Description in input context": "E312K variant in UBR5"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Cancer",
    "MONDO": "MONDO:0005138"
  },
  "Experiment Method": [
    {
      "Assay Method": "Western Blot",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "HEK293",
        "Description": "HEK293 cells were transfected with wild-type or mutant UBR5 plasmids."
      },
      "Readout Type": "Quantitative",
      "Readout Description": [
        {
          "Variant": "UBR5 E312K",
          "Conclusion": "UBR5 E312K enhances p53 protein stability, leading to increased p53 levels compared to wild-type UBR5.",
          "Molecular Effect": "Gain-of-function"
        }
      ],
      "Replicates": {
        "Biological": "3",
        "Technical": "3"
      },
      "Controls": {
        "Positive": "Wild-type UBR5",
        "Negative": "Empty vector"
      },
      "Statistical Analysis": "ANOVA",
      "Thresholds": {
        "Normal": "p53 levels below a threshold corresponding to wild-type UBR5",
        "Abnormal": "p53 levels above the threshold in E312K mutant"
      },
      "Approved Assay": "Yes"
    }
  ]
}